| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.008 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.009 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.009 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.089 | 0.009 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |